| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
hsa-miR-6873-3p, hsa-miR-6833-3p, hsa-miR-6845-3p, hsa-miR-6742-5p, hsa-miR-100-3p |
| Biological function: |
Proposed diagnostic biomarker (in combination) and potentially involved in carcinogenesis. |
| Molecular mechanism: |
Predicted miRNA sequestration via MREs (miRNA sponge/ceRNA-like mechanism). |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; divergent primers PCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Diagnostic performance assessed by ROC; in combination with hsa_circ_006054 and hsa_circ_100219 AUC = 0.82 (95% CI: 0.73-0.90). |
| Description: |
hsa_circ_406697 is down-regulated in breast cancer tissues and, when combined with hsa_circ_006054 and hsa_circ_100219, improves diagnostic discrimination (AUC 0.82); it is predicted to interact with several miRNAs including hsa-miR-100-3p. |
| Confidence score: |
0.5963 |